PTEN and angiosarcoma: We developed a novel and robust genetically engineered mouse model for angiosarcoma through the combined deletion of Pten, Trp53, and Ptpn12. Conditional deletion of all three genes results in aggressive cutaneous tumors in mice that develop rapidly and with virtually 100% penetrance.